RANI
Rani Therapeutics Holdings, Inc.NASDAQHealthcare$0.84+4.27%ClosedMarket Cap: $54.9M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.70
P/S
33.20
EV/EBITDA
-1.07
DCF Value
$0.35
FCF Yield
-34.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.0%
Operating Margin
-2345.9%
Net Margin
-1817.1%
ROE
-718.5%
ROA
-50.6%
ROIC
-80.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.5M | 87.3% | $-8.5M | $-10.3M | $-0.07 | — |
| FY 2025 | $1.6M | 44.9% | $-38.3M | $-29.7M | $-0.45 | — |
| Q3 2025 | $0.00 | -Infinity% | $-7.3M | $-5.4M | $-0.12 | — |
| Q2 2025 | $0.00 | NaN% | $-10.5M | $-6.7M | $-0.18 | — |
| Q1 2025 | $172.0K | 100.0% | $-12.0M | $-7.3M | $-0.22 | — |
| Q4 2024 | $1.0M | 100.0% | $-15.0M | $-8.9M | $-0.27 | — |
| FY 2024 | $1.0M | 100.0% | $-53.3M | $-30.0M | $-1.05 | — |
| Q3 2024 | $0.00 | NaN% | $-11.8M | $-6.8M | $-0.24 | — |
| Q2 2024 | $0.00 | NaN% | $-12.5M | $-6.8M | $-0.26 | — |
| Q1 2024 | $0.00 | -Infinity% | $-14.0M | $-7.5M | $-0.29 | — |
| Q4 2023 | $0.00 | NaN% | $-13.4M | $-7.1M | $-0.27 | — |
| FY 2023 | $0.00 | -Infinity% | $-66.1M | $-34.0M | $-1.33 | — |